Provides cloud software that automates billing, claims and payment processes (revenue cycle management) for healthcare providers.
Provides cloud software that automates billing, claims and payment processes (revenue cycle management) for healthcare providers.
Paid by providers under recurring contracts that combine software subscriptions with fees tied to the volume of claims and payments it processes, so revenue grows when customers send more through. Its platform sits between hospitals and thousands of insurers. Listed in 2024 with EQT and CPP Investments as large holders.
Moat: narrow (switching costs, installed base, scale). Deep integration into hospital billing workflows and payer connections creates high switching costs.
Headquarters: Louisville, Kentucky, United States · Founded: 2017 · Employees: 1,700
Size Waystar (WAY) is a United States Information Technology company (Packaged Software) with a market value of $5.30B, the 1134th largest of 3,085 United States companies the cockpit tracks. Shares closed at $27.54 on 18 Nov 2026.
Performance Over six months the shares gained 43.4%, against +6.4% for the median peer and -2.2% for the United States market (cap-weighted) — 7th highest of 19 in its peer set.
Growth Revenue grew 21.4% over the last twelve months (peer median +13.5%); the operating margin is 24.5% (peer median 15.2%).
Valuation It trades at 15.3× forward earnings against a peer median of 21.0× (5th cheapest of 18).
Price implies For today's price to make sense, revenue must grow about 8% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is -8 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 1.7 points below its cost of capital (6.3% WACC).
Short interest Short interest is 7.8% of the free float (30 Oct 2026).
Next results Next results expected around 23 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $1.26B | $1.10B | $944M | $791M | $705M |
| Revenue growth | — | +17% | +19% | +12% | — |
| Gross profit | $711M | $611M | $441M | $365M | $307M |
| EBITDA | $474M | $418M | $327M | $323M | $288M |
| Net income | $135M | $112M | -$19.1M | -$51.3M | -$51.5M |
| Free cash flow | $264M | $283M | $142M | $29.9M | $85.2M |
| Capital expenditure | $50.8M | $26.5M | $27.3M | $21.5M | $17.4M |
| Total debt | $1.48B | $1.49B | $1.26B | $2.25B | $2.26B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Waystar WAY | $5.30B | +43% | +21% | 24% | 15.3× | 7.6% |
| UnitedHealth UNH | $314B | -8% | +3% | 5% | 15.4× | 3.1% |
| Phreesia PHR | $761M | +39% | +13% | 5% | 21.6× | 13.2% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | WAY | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -4.4% | -4.4% | 11th highest of 21 |
| 6-month return | +43.4% | +6.4% | 7th highest of 19 |
| Distance from 52-week high | -26.6% | -29.0% | 10th highest of 21 |
| Revenue growth (TTM) | +21.4% | +13.5% | 8th highest of 21 |
| Operating margin | 24.5% | 15.2% | 5th highest of 21 |
| Forward P/E | 15.3× | 21.0× | 5th cheapest of 18 |
| Growth the price implies (Req g, 7 yrs) | 7.6% | 17.2% | 7th least demanding of 17 |
| Growth delivered (Del g) | +16.0% | +12.7% | 8th highest of 17 |
| Hurdle (Req g minus delivered) | -8.4 pp | -2.5 pp | 8th least demanding of 17 |
| ROIC minus cost of capital | -1.7 pp | +0.3 pp | 9th lowest of 21 |
| EV / EBITDA | 13.7× | 15.3× | 6th cheapest of 13 |
| Net debt / EBITDA | 2.5× | 0.4× | 3rd most indebted of 14 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Waystar WAY | United States | $5.30B | +43% | +21% | 24% | 15.3× | 7.6% | +16.0% |
| ACI Worldwide ACIW | United States | $5.30B | +22% | +2% | 15% | 18.7× | 13.7% | +6.3% |
| Dolby Laboratories DLB | United States | $5.32B | +5% | +5% | 23% | 12.9× | 4.9% | +2.1% |
| Sezzle SEZL | United States | $5.36B | +116% | +39% | 42% | 23.7× | 27.4% | +50.3% |
| AutoStore AUTO.OL | Norway | $5.39B | +16% | +27% | 32% | 27.1× | 19.2% | +27.0% |
| iSoftStone Information Technology (Group) 301236.SZ | China | $5.20B | -12% | +13% | 0% | 106.6× | n/a | n/a |
| Giant Network 002558.SZ | China | $5.16B | -39% | +105% | 48% | 8.9× | -3.7% | +17.9% |
| Doximity DOCS | United States | $5.47B | +59% | +6% | 27% | 21.2× | 17.0% | +25.5% |
| NIQ Global Intelligence NIQ | United States | $5.13B | +103% | +9% | 10% | 13.2× | 3.1% | +14.6% |
| Beijing Deepzero Technology 2947.HK | Hong Kong | $5.13B | n/a | +31% | 1% | n/a | n/a | n/a |
| SenseTime 0020.HK | Hong Kong | $5.53B | -43% | +31% | -51% | n/a | n/a | n/a |
| Open Text OTEX.TO | Canada | $5.55B | +5% | -1% | 23% | 6.0× | -6.8% | +10.8% |
| BlackBerry BB.TO | Canada | $5.02B | +44% | +14% | 16% | 40.5× | 33.8% | -8.6% |
| MiniMax 0100.HK | Hong Kong | $5.00B | -84% | +159% | -407% | n/a | n/a | n/a |
| Hundsun Technologies 600570.SS | China | $5.66B | -21% | -5% | 9% | 27.8× | 33.5% | +7.0% |
| BILL BILL | United States | $5.67B | +72% | +7% | 7% | 16.1× | 26.2% | +47.3% |
| Varonis Systems VRNS | United States | $5.68B | +58% | +18% | -26% | 136.4× | 23.7% | +16.3% |
| Shanghai Baosight Software 600845.SS | China | $5.71B | -28% | +11% | 10% | 30.0× | 6.2% | +1.4% |
| Octave Intelligence OCTV | United States | $5.72B | n/a | +1% | 20% | 15.4× | 17.5% | +1.3% |
| Mphasis MPHASIS.NS | India | $4.89B | +8% | +15% | 15% | 21.0× | 27.6% | +10.6% |
| Topicus.com TOI.V | Canada | $5.79B | 0% | +24% | 16% | 20.6× | -0.6% | +26.5% |